AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Uniphar Group PLC (LSE:UPR)
174 GBP
+6.000 3.571%Sponsored Reports
Loading...
| Previous Close (in GBP) | 168 |
|---|---|
| Change | +6.000 3.571% |
| 52 W H/L (in GBP) | 331.561/178.000 |
| EBITDA (in GBP) | 83.649M |
| PE Ratio | 15.64 |
| Volume | 10730 |
| Diluted Eps TTM | 0.14 |
| Total Assets (in GBP) | 1110.794M |
|---|---|
| Total Liabilities (in GBP) | 821.011M |
| Revenue TTM (in GBP) | 2318.42M |
| Cash (in GBP) | 103.704M |
| Market Cap (in GBP) | 604.696 M |
| Revenue Per Share TTM | 8.498 |
| Gross Profit TTM (in GBP) | 306.744M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Uniphar Group PLC
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which offers access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that provides bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
Employees: 2800
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Gerard Rabbette B.Comm FCA | CEO & Exec. Director | NA |
| 2. | Mr. Timothy Dolphin B.Comm FCA | CFO & Exec. Director | NA |
| 3. | Mr. Padraic Dempsey | Chief Commercial Officer | NA |
| 4. | Mr. Seamus Egan | Head of Corp. Devel. & Investor Relations | NA |
| 5. | Ms. Aisling McCarthy | Gen. Counsel & Company Sec. | NA |
| 6. | Mr. Dermot Ryan | Managing Director | NA |
No data found
Income Statement
(Currency in GBP)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | 54.676M | 55.801M | 33.531M | 26.458M | 21M |
| Minority Interest | -0.119M | -0.045M | 0.075M | -0.285M | -0.18M |
| Net Income | 45.587M | 48.077M | 27.827M | 21.026M | 17.3M |
| Selling General Administrative | 183.69M | 154.471M | 115.328M | 88.41M | 76.1M |
| Gross Profit | 306.744M | 274.497M | 217.252M | 180.602M | 159.6M |
| Reconciled Depreciation | 28.47M | 26.93M | 19.994M | 18.305M | 7.236M |
| Ebit | 53.155M | 45.147M | 39.944M | 40.007M | 27.3M |
| Ebitda | 81.382M | 86.215M | 66.456M | 58.312M | 34.536M |
| Depreciation And Amortization | 28.227M | 41.068M | 26.512M | 18.305M | 7.236M |
| Operating Income | 53.155M | 45.147M | 39.944M | 40.007M | 36.7M |
| Other Operating Expenses | 2017.514M | 1883.598M | 1777.135M | 1625.033M | 1515.4M |
| Interest Expense | 9.29M | 6.926M | 5.869M | 6.508M | 6.3M |
| Tax Provision | 8.97M | 7.679M | 5.72M | 5.537M | 3.7M |
| Interest Income | 0.096M | 0.037M | 0.011M | 0.039M | 4.024M |
| Net Interest Income | -9.533M | -7.192M | -6.126M | -6.755M | -6.3M |
| Income Tax Expense | 8.97M | 7.679M | 5.72M | 5.537M | 3.7M |
| Total Revenue | 2070.669M | 1943.149M | 1823.854M | 1665.283M | 1552.1M |
| Total Operating Expenses | 253.589M | 214.946M | 170.533M | 140.352M | 122.9M |
| Cost Of Revenue | 1763.925M | 1668.652M | 1606.602M | 1484.681M | 1392.5M |
| Total Other Income Expense Net | 1.521M | 10.654M | -6.413M | -13.549M | -15.7M |
| Net Income From Continuing Ops | 45.706M | 48.122M | 27.811M | 20.921M | 17.3M |
| Net Income Applicable To Common Shares | 45.587M | 48.077M | 27.827M | 21.026M | 8.642M |
Balance Sheet
(Currency in GBP)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Total Assets | 1110.794M | 944.993M | 840.455M | 760.623M | 654.9M |
| Intangible Assets | 24.459M | 20.777M | 16.215M | 5.232M | 6.761M |
| Other Current Assets | 165.812M | -129340.343M | -108178.407M | -118623.093M | 183.2M |
| Total Liab | 821.011M | 693.429M | 637.92M | 579.703M | 506M |
| Total Stockholder Equity | 289.544M | 251.444M | 202.46M | 181.205M | 149.1M |
| Other Current Liab | 4.59M | 4.295M | 0.374M | 5M | 2.5M |
| Common Stock | 21.841M | 21.841M | 21.841M | 21.841M | 20.3M |
| Capital Stock | 21.841M | 21.841M | 21.841M | 21.841M | 20.3M |
| Retained Earnings | 88.476M | 47.555M | 5.218M | -20.601M | -31.9M |
| Good Will | 482.981M | 425.16M | 358.283M | 270.727M | 200.217M |
| Other Assets | 9.529M | 2.554M | 5.633M | 5.808M | 15.148M |
| Cash | 103.704M | 78.025M | 60.41M | 114.04M | 106.7M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 433.601M | 373.707M | 348.761M | 348.166M | 345.2M |
| Current Deferred Revenue | - | -4.295M | -0.374M | - | - |
| Net Debt | 211.451M | 167.375M | 158.053M | 68.504M | 59.1M |
| Short Term Debt | 21.805M | 16.079M | 15.645M | 32.666M | 81.8M |
| Short Long Term Debt | 7.49M | 1.721M | 2.311M | 22.583M | 81.8M |
| Short Long Term Debt Total | 315.155M | 245.4M | 218.463M | 182.544M | 165.8M |
| Other Stockholder Equity | 179.227M | 182.048M | 175.401M | 179.965M | 160.7M |
| Property Plant Equipment | 166.628M | 152.483M | 153.73M | 119.483M | 23.141M |
| Total Current Assets | 427.172M | 343.994M | 306.569M | 359.052M | 369.8M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 164.212M | 129494M | 108309M | 118770M | 165.725M |
| Long Term Debt | 187.431M | 124.601M | 95.615M | 66.977M | 84M |
| Inventory | 157.656M | 112.312M | 115.566M | 98.105M | 79.9M |
| Accounts Payable | 407.206M | 357.628M | 333.116M | 310.5M | 260.9M |
| Accumulated Other Comprehensive Income | - | - | -43.94M | -33.705M | - |
| Non Currrent Assets Other | 0.534M | 0.413M | 1.134M | 1.157M | 8M |
| Non Current Assets Total | 683.622M | 600.999M | 533.886M | 401.571M | 285.1M |
| Capital Lease Obligations | 120.234M | 119.078M | 120.537M | 92.984M | - |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in GBP)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -106.332M | -49.658M | -110.326M | -45.644M | -82.005M |
| Total Cashflows From Investing Activities | -106.332M | -49.658M | -110.326M | -45.644M | -82.005M |
| Total Cash From Financing Activities | 50.405M | 13.259M | -8.715M | 42.148M | 100.094M |
| Net Income | 69.57M | 59.551M | 46.719M | 33.175M | 17.3M |
| Change In Cash | 25.679M | 17.615M | -53.63M | 103.501M | 9.351M |
| Begin Period Cash Flow | 78.025M | 60.41M | 114.04M | 10.539M | 1.188M |
| End Period Cash Flow | 103.704M | 78.025M | 60.41M | 114.04M | 10.539M |
| Total Cash From Operating Activities | 82.831M | 52.177M | 65.978M | 106.997M | -8.738M |
| Depreciation | 28.47M | 26.93M | 19.994M | 18.305M | 7.236M |
| Other Cashflows From Investing Activities | - | - | 1.027M | 1.027M | 1.027M |
| Dividends Paid | 4.666M | 5.731M | 1.993M | 1.993M | 1.993M |
| Change To Inventory | -15.13M | 3.726M | -11.868M | -14.889M | -1.109M |
| Sale Purchase Of Stock | - | - | - | 140.619M | 0.246M |
| Other Cashflows From Financing Activities | 84.646M | 32.936M | 98.711M | -22.26M | 120.182M |
| Capital Expenditures | 19.921M | 14.429M | 15.737M | 6.446M | 4.895M |
| Change In Working Capital | -9.496M | -9.055M | 10.475M | -2.121M | -28.783M |
| Other Non Cash Items | -6.248M | -25.249M | -11.21M | 57.638M | -4.491M |
| Free Cash Flow | 62.91M | 37.748M | 50.241M | 100.551M | -13.633M |
No data found
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...
